Guides, comparisons, and research summaries for people trying to understand how ibogaine’s legal status differs by country and context.
Juravine is an independent resource on ibogaine laws across jurisdictions. Its services organize country-level information into practical guides, comparison tools, research summaries, glossary context, and FAQ collections without presenting medical or legal conclusions.
The country-by-country legal overview is designed to make differences visible: a substance may be controlled in one place, unlisted in another, or subject to rules that cannot be understood from a single label alone. For the principles behind that work, see Juravine’s approach to jurisdictional accuracy.
Each offering is informational. It is intended to help individuals, families, researchers, and policy-minded visitors separate a headline legal category from the questions beneath it.
The country table brings legal categories into a comparable view and points readers toward the need for jurisdiction-specific verification. Questions about whether ibogaine is illegal in the United States illustrate why a single country entry should not substitute for current legal review.
Plain-language guides explain distinctions among controlled-substance listings, possession, importation, supply, research, and treatment claims. The meaning of an ibogaine treatment can involve separate health and legal questions, so those contexts are kept distinct.
Glossary-style explanations clarify terms that can alter a search or a legal interpretation. For example, discussion of ibogaine street-name terminology is kept separate from formal legal naming and controlled-substance language.
Research-oriented summaries identify the difference between a claim, a study topic, and a regulatory conclusion. Searches around ibogaine and PTSD treatment are an example of why health information requires careful boundaries and source context.
Legal descriptions need context about terminology, date, jurisdiction, and source. International drug-control frameworks also matter: the United Nations Single Convention on Narcotic Drugs is an official reference point for understanding the treaty system that informs many national approaches.
Juravine’s comparison and guide pages keep health-related searches separate from legal claims. This includes common queries concerning ibogaine treatment for addiction, ibogaine treatment for alcohol, and ibogaine for alcohol addiction.
“Controlled” is not a complete description of legal reality. It may leave unanswered questions about schedules, analog provisions, professional regulation, import rules, and how current sources describe a substance.
A useful comparison starts with the scope of a claim, then traces it back to the jurisdiction and source that support it. This approach is especially important when visitors encounter location-specific material such as Baja ibogaine treatment information, where travel, regulation, and health contexts can overlap.
For background on the substance itself, the Ibogaine overview on Wikipedia provides a general reference that is distinct from a current legal determination.
These answers describe how to use an informational comparison responsibly. They do not replace jurisdiction-specific legal or medical guidance.
It separates a high-level legal category from the practical questions that remain: which substance rule may apply, whether exceptions exist, how rules are enforced, and what information should be checked directly with current official sources.
Drug law and regulatory practice can change, may differ across national and local jurisdictions, and can depend on facts not captured in a summary. Juravine is an independent information resource, not a clinic, medical provider, or licensed treatment center.
They address searches readers may already be making, including material connected with the ibogaine documentary context. Their inclusion does not endorse a service, establish a legal pathway, or make a health claim.
The site’s legal guides and source materials are designed to show why provenance matters. For U.S.-specific controlled-substance context, the DEA’s drug scheduling information is an official starting point, but current rules should always be checked in the relevant jurisdiction.
Use Juravine’s table as a structured starting point for comparing legal status across jurisdictions, with uncertainty and source limits kept visible.